Ulcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves' diseaseTumor necrosis factor-alpha binding capacity and anti-infliximab antibodies measured by fluid-phase radioimmunoassays as predictors of clinical efficacy of infliximab in Crohn's disease

Fassi D. El; J. Kjeldsen; O. Clemmensen; L. Hegedus; Claus Henrik Nielsen

Ulcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves' diseaseTumor necrosis factor-alpha binding capacity and anti-infliximab antibodies measured by fluid-phase radioimmunoassays as predictors of clinical efficacy of infliximab in Crohn's disease

Fassi D. El, J. Kjeldsen, O. Clemmensen, L. Hegedus, Claus Henrik Nielsen

100 Citations (Scopus)

Abstract

Udgivelsesdato: 2008/5

Original language	English
Journal	Gut
Volume	57
Issue number	5
Pages (from-to)	714-715
Number of pages	1
ISSN	0017-5749
Publication status	Published - 2008

Cite this

El, F. D., Kjeldsen, J., Clemmensen, O., Hegedus, L., & Nielsen, C. H. (2008). Ulcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves' diseaseTumor necrosis factor-alpha binding capacity and anti-infliximab antibodies measured by fluid-phase radioimmunoassays as predictors of clinical efficacy of infliximab in Crohn's disease. Gut, 57(5), 714-715.

Ulcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves' diseaseTumor necrosis factor-alpha binding capacity and anti-infliximab antibodies measured by fluid-phase radioimmunoassays as predictors of clinical efficacy of infliximab in Crohn's disease. / El, Fassi D.; Kjeldsen, J.; Clemmensen, O. et al.

In: Gut, Vol. 57, No. 5, 2008, p. 714-715.

Research output: Contribution to journal › Journal article › Research › peer-review

El, FD, Kjeldsen, J, Clemmensen, O, Hegedus, L & Nielsen, CH 2008, 'Ulcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves' diseaseTumor necrosis factor-alpha binding capacity and anti-infliximab antibodies measured by fluid-phase radioimmunoassays as predictors of clinical efficacy of infliximab in Crohn's disease', Gut, vol. 57, no. 5, pp. 714-715.

El, Fassi D. ; Kjeldsen, J. ; Clemmensen, O. et al. / Ulcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves' diseaseTumor necrosis factor-alpha binding capacity and anti-infliximab antibodies measured by fluid-phase radioimmunoassays as predictors of clinical efficacy of infliximab in Crohn's disease. In: Gut. 2008 ; Vol. 57, No. 5. pp. 714-715.

@article{b9c79140986b11de8bc9000ea68e967b,

title = "Ulcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves' diseaseTumor necrosis factor-alpha binding capacity and anti-infliximab antibodies measured by fluid-phase radioimmunoassays as predictors of clinical efficacy of infliximab in Crohn's disease",

abstract = "Udgivelsesdato: 2008/5",

author = "El, {Fassi D.} and J. Kjeldsen and O. Clemmensen and L. Hegedus and Nielsen, {Claus Henrik}",

year = "2008",

language = "English",

volume = "57",

pages = "714--715",

journal = "Gut",

issn = "0017-5749",

publisher = "B M J Group",

number = "5",

}

TY - JOUR

T1 - Ulcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves' diseaseTumor necrosis factor-alpha binding capacity and anti-infliximab antibodies measured by fluid-phase radioimmunoassays as predictors of clinical efficacy of infliximab in Crohn's disease

AU - El, Fassi D.

AU - Kjeldsen, J.

AU - Clemmensen, O.

AU - Hegedus, L.

AU - Nielsen, Claus Henrik

PY - 2008

Y1 - 2008

N2 - Udgivelsesdato: 2008/5

AB - Udgivelsesdato: 2008/5

M3 - Journal article

SN - 0017-5749

VL - 57

SP - 714

EP - 715

JO - Gut

JF - Gut

IS - 5

ER -